Dose Proportionality and Steady-State Pharmacokinetics of Serdexmethylphenidate/Dexmethylphenidate, a Novel Prodrug Combination to Treat Attention-Deficit/Hyperactivity Disorder
Author:
Affiliation:
1. KemPharm, Inc., Celebration, Florida, USA.
2. Corium, Inc., Grand Rapids, Michigan, USA.
Publisher
Mary Ann Liebert Inc
Subject
Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology and Child Health
Link
https://www.liebertpub.com/doi/pdf/10.1089/cap.2022.0015
Reference17 articles.
1. A Randomized, Double-Blind, Crossover Study of Once-Daily Dexmethylphenidate in Children with Attention-Deficit Hyperactivity Disorder
2. Efficacy and Safety of Multilayer, Extended-Release Methylphenidate (PRC-063) in Children 6–12 Years of Age with Attention-Deficit/Hyperactivity Disorder: A Laboratory Classroom Study
3. Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies
4. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis
5. Prevalence of Parent-Reported ADHD Diagnosis and Associated Treatment Among U.S. Children and Adolescents, 2016
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prodrugs as empowering tools in drug discovery and development: recent strategic applications of drug delivery solutions to mitigate challenges associated with lead compounds and drug candidates;Chemical Society Reviews;2024
2. Pediatric attention deficit hyperactivity disorder (ADHD): 2022 updates on pharmacological management;Expert Review of Clinical Pharmacology;2023-08-22
3. Advancements in Drug Repurposing: Examples in Psychiatric Medications;International Journal of Molecular Sciences;2023-07-01
4. Evaluating serdexmethylphenidate and dexmethylphenidate capsules as a once-daily treatment option for ADHD;Expert Opinion on Pharmacotherapy;2023-05-26
5. Epilepsy and Attention Deficit Hyperactivity Disorder: Connection, Chance, and Challenges;International Journal of Molecular Sciences;2023-03-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3